Patents Represented by Attorney, Agent or Law Firm Jennifer Wahlsten
  • Patent number: 8221986
    Abstract: The invention provides methods of preparing a test sample for use in an assay for detecting an analyte bound by an intracellular ligand. The methods typically involve contacting the test sample with an assay reagent comprising: a lysis reagent; and a protease that has proteolytic activity for said intracellular ligand; to form a mixture compatible for use in an immunoassay without subsequent extraction steps. Other aspects of the invention include related immunoassays and test kits.
    Type: Grant
    Filed: June 25, 2009
    Date of Patent: July 17, 2012
    Assignee: Abbott Laboratories
    Inventors: Frank C. Grenier, Ryan F. Workman, Hina N. Syed, Salman Ali
  • Patent number: 7993851
    Abstract: The invention provides a lysis reagent and method for preparing a test sample for use in an assay, wherein the method yields a homogeneous lysis mixture suitable for use in automated pipetting systems without the need for a centrifugation step. The lysis reagent includes a glycol and non-specific animal immunoglobulins. Other aspects of the invention include related immunoassays and test kits.
    Type: Grant
    Filed: June 25, 2009
    Date of Patent: August 9, 2011
    Assignee: Abbott Laboratories
    Inventor: Shelley R. Holets-McCormack
  • Patent number: 6329570
    Abstract: Novel methods are provided whereby encoding sequences preferentially directing gene expression in ovary tissue, particularly in very early fruit development, are utilized to express genes encoding isopentenyl transferase in cotton ovule tissue. The methods permit the modification of the characteristics of boll set in cotton plants and provide a mechanism for altering fiber quality characteristics including fiber dimension and strength.
    Type: Grant
    Filed: February 28, 1995
    Date of Patent: December 11, 2001
    Assignee: Calgene, LLC
    Inventor: Belinda Martineau
  • Patent number: 6281410
    Abstract: Regulatory regions from genes expressed during a particular developmental stage or in a specific tissue are identified employing cDNA screening. The resulting regulatory regions are manipulated for use with foreign sequences for introduction into plant cells to provide transformed plants having phenotypic property which can be modulated. The invention is exemplified with light, seed and a fruit-specific promoters.
    Type: Grant
    Filed: January 15, 1999
    Date of Patent: August 28, 2001
    Assignee: Calgene LLC
    Inventors: Vic C. Knauf, Jean C. Kridl
  • Patent number: 6268546
    Abstract: Novel DNA constructs are provided which may be used as molecular probes or inserted into a plant host to provide for modification of transcription of a DNA sequence of interest in ovary tissue, particularly in very early fruit development. The DNA constructs comprise a transcriptional initiation regulatory region associated with gene expression in ovary tissue from immediately prior to anthesis through flower senescence.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 31, 2001
    Assignee: Calgene LLC
    Inventors: Kevin McBride, David Stalker
  • Patent number: 6238669
    Abstract: Circular double-stranded replication intermediates were identified in low-molecular-weight DNA of cells of the avian leukemia virus-induced lymphoblastoid cell line 1104-X-5 infected with chicken anemia virus (CAV). To characterize the genome of CAV, we cloned linearized CAV DNA into the vector pIC20H. Transfection of the circularized cloned insert into chicken cell lines caused a cytopathogenic effect, which was arrested when a chicken serum with neutralizing antibodies directed against CAV was added. The 2,319-bp cloned CAV DNA contained all the genetic information needed for the complete replication cycle of CAV. The CAV genome probably contains only one promoter region and only one poly(A) addition signal. Southern blot analysis using oligomers derived from the CAV DNA sequence showed that infected cells contained double- and single-stranded CAV DNAs, whereas purified virus contained only the minus strand.
    Type: Grant
    Filed: August 13, 1997
    Date of Patent: May 29, 2001
    Assignee: Leadd, bv
    Inventors: Mathews H. M. Noteborn, Gerden F. De Boer
  • Patent number: 6222097
    Abstract: Novel DNA constructs are provided which may be used as molecular probes or inserted into a plant host to provide for modification of transcription of a DNA sequence of interest in ovary tissue, particularly in very early fruit development. The DNA constructs comprise a transcriptional initiation regulatory region associated with gene expression in ovary tissue from immediately prior to anthesis through flower senescence.
    Type: Grant
    Filed: December 3, 1997
    Date of Patent: April 24, 2001
    Assignee: Calgene, LLC
    Inventors: Kevin E. McBride, David M. Stalker
  • Patent number: 6217870
    Abstract: The coding information for three putative chicken anemia virus proteins (VP1, VP2, VP3) was inserted into a baculovirus vector and expressed in insect cells. The immunogenic properties of the chicken anemia virus (CAV) proteins produced separately or together in insect-cell cultures were analyzed by inoculating them into chickens. Only lysates of insect cells which have synthesized equivalent amounts of all three recombinant CAV proteins or cells which synthesized mainly VP1 plus VP2 induced neutralizing antibodies directed against CAV in inoculated chickens. Progeny of those chickens were protected against clinical disease after CAV challenge. Inoculation of a mixture of lysates of cells that were separately infected with VP1-, VP2- and VP3-recombinant baculovirus did not induce significant levels of neutralizing antibody directed against CAV and their progeny were not protected against CAV challenge.
    Type: Grant
    Filed: April 9, 1998
    Date of Patent: April 17, 2001
    Assignee: Leadd, bv
    Inventors: Mathieu Hubertus Maria Noteborn, Guus Koch